吉吉吉吉的可以通过多种信号通路缓解酒精性肝病
Yangyang Chen1, Tinghui Gao1, Jing Bai2
1State Key Laboratory of Southwestern Chinese Medicine Resources, College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Journal of ethnopharmacology
|September 23, 2024
概括
吉吉吉 (Ge-Zhi-Jie-Jiu decoction,简称JJY) 通过向多个途径,有效治疗酒精性肝病 (ALD). 本研究确定了关键的化合物和机制,支持JJYY.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
- 传统中国医药 传统中国医药
背景情况:
- 酒精性肝病 (ALD) 是一个重大的公共卫生挑战,治疗选择有限.
- 吉吉吉 (Ge-Zhi-Jie-Jiu decoction,简称JJY) 是一种经过修改的中国传统草药,被提议用于ALD治疗,但其活性成分和机制尚不清楚.
研究的目的:
- 阐明JJY在改善酒精性肝病 (ALD) 的分子机制和药理动力学基础.
- 为了确定JJY中关键的活性化合物,负责其治疗作用.
主要方法:
- 使用UPLC-Q-Orbitrap HRMS,HPLC指纹和LC-MS进行JJY的组合分析.
- 网络药理学和分子对接被用来预测治疗点和机制.
- 一个急性酒精性肝损伤小鼠模型被用于通过组织学,分子和生物化学分析进行体内验证.
主要成果:
- JJY含有丰富的有机酸,黄酸和异黄酸,其中氨酸,乳氨酸,甘油氨酸,氨酸,氨酸和氨酸被确定为关键指标成分.
- 通过提高酒精代谢,通过Nrf2/Keap1/HO-1和MAPK信号通路抑制氧化应激,炎症和亡,JJY显示了改善ALD的潜力.
- 通过PPARα信号通路,JJY减少了肝脂积累.
结论:
- 通过多目标机制,JJY对ALD表现出显著的疗效.
- 这项研究为JJY作为ALD潜在治疗剂的开发提供了坚实的科学基础.
- 该研究成功地确定了可能的活性成分,并阐明了JJY的潜在药理作用.
相关概念视频
Liver Regeneration
4.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.2K
Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
275
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
275
Cirrhosis II: Pathophysiology
53
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
53


